Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort-term InvestmentsWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Short-term Investments: 2020-2024

Historic Short-term Investments for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to $317,000.

  • Burning Rock Biotech's Short-term Investments rose 947.50% to $419,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $419,000, marking a year-over-year increase of 947.50%. This contributed to the annual value of $317,000 for FY2024, which is 1764.71% up from last year.
  • Burning Rock Biotech's Short-term Investments amounted to $317,000 in FY2024, which was up 1,764.71% from $17,000 recorded in FY2023.
  • In the past 5 years, Burning Rock Biotech's Short-term Investments ranged from a high of $55.5 million in FY2020 and a low of $17,000 during FY2023.
  • Its 3-year average for Short-term Investments is $1.1 million, with a median of $317,000 in 2024.
  • Per our database at Business Quant, Burning Rock Biotech's Short-term Investments tumbled by 99.41% in 2023 and then soared by 1,764.71% in 2024.
  • Burning Rock Biotech's Short-term Investments (MRY) stood at $55.5 million in 2020, then tumbled by 81.97% to $10.0 million in 2021, then crashed by 71.28% to $2.9 million in 2022, then tumbled by 99.41% to $17,000 in 2023, then soared by 1,764.71% to $317,000 in 2024.
  • Its Short-term Investments was $317,000 in FY2024, compared to $17,000 in FY2023 and $2.9 million in FY2022.